Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study

Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies

(2012) Isabel Fofana et al.   GASTROENTEROLOGY

Viral Hepatitis in Liver Transplantation

(2012) Gonzalo Crespo et al.   GASTROENTEROLOGY

Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees

(2012) Trevor J. Morin et al.   PLoS Pathogens

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus

(2011) Jean-Michel Pawlotsky   HEPATOLOGY

Polyclonal Immunoglobulins and Hyperimmune Globulins in Prevention and Management of Infectious Diseases

(2011) Jennifer L. Hsu et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

(2011) Natalie Bzowej et al.   LIVER TRANSPLANTATION

Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation

(2010) B. Degertekin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

(2010) Samira Fafi-Kremer et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

(2009) T. J. Broering et al.   JOURNAL OF VIROLOGY

Natural history of post–liver transplantation hepatitis C: A review of factors that may influence its course

(2009) Juan F. Gallegos-Orozco et al.   LIVER TRANSPLANTATION